DeveloGen Diabetes Pax4 Gene Therapy Enters Late Preclinicals
Executive Summary
A gene therapy approach to treat diabetes has passed through several validation screens and is now being tested in higher mammals including primates, DeveloGen VP-Corporate Affairs Edward Stuart, PhD, told the Ernst & Young/Atlas Venture European Life Sciences Conference April 17 in Amsterdam.